# Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

> **NCT02839915** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Southwest Autism Research & Resource Center** · enrollment: 56 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Folinic Acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02839915
- **Lead sponsor:** Southwest Autism Research & Resource Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-08-13
- **Primary completion:** 2024-04-15
- **Final completion:** 2026-07-31
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02839915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02839915, "Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02839915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*